Unlocking New Treatment Horizons for Celiac Disease: PRKCD Revealed as a Promising Target through Mendelian Randomization
Our study is the first to identify the PRKCD gene as a potential therapeutic target for treating CeD, providing new insights into the treatment of CeD and guiding the development of corresponding therapeutic drugs.
Authors
- Chao Chen (ORCID: https://orcid.org/0000-0003-0832-8046)
- Yang Xu (ORCID: https://orcid.org/0000-0003-1670-6131)
- Haitao Wang (ORCID: https://orcid.org/0000-0002-8470-064X)
- Kun Wang (ORCID: https://orcid.org/0000-0003-2513-768X)
- Jie Zhou (ORCID: https://orcid.org/0000-0002-4096-1442)
Institutions
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Soochow University (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-08-29
- DOI
- https://doi.org/10.2174/0118715303410531250815124524
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00